This study did not have a control group of patients
with breast cancer who were not receiving adjuvant
hormonal therapy. A control group would have allowed
for the validation that the symptoms stemmed
only from the hormonal therapy. An additional control
group may have been needed to distinguish between
the effects of menopausal symptoms on women without
breast cancer as compared to symptoms experienced by
women with breast cancer receiving hormonal therapy.